Jordi Giralt

Summary

Affiliation: Hospital Universitari Vall d'Hebron
Country: Spain

Publications

  1. ncbi Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer
    Jacques Bernier
    Department of Radio Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
    N Engl J Med 350:1945-52. 2004
  2. ncbi Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiation-induced diarrhea: results from multicenter, randomized, placebo-controlled nutritional trial
    Jordi Giralt
    Department of Radiation Oncology, Vall d Hebron University Hospital, Barcelona, Spain
    Int J Radiat Oncol Biol Phys 71:1213-9. 2008
  3. ncbi Pre-operative chemoradiotherapy with UFT and Leucovorin in patients with advanced rectal cancer: a phase II study
    Jordi Giralt
    Department of Radiation Oncology, Vall d Hebron University Hospital, Barcelona, Spain
    Radiother Oncol 89:263-9. 2008
  4. ncbi Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy
    Jordi Giralt
    Department of Radiation Oncology, Hospital Vall d Hebron, Barcelona, Spain
    Oncology 71:312-9. 2006
  5. ncbi The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multicenter, retrospective analysis
    Jordi Giralt
    Department of Radiation Oncology, Hospital Universitari Vall d'Hebron, Barcelona, Spain
    Radiother Oncol 74:101-8. 2005
  6. ncbi Overexpression of phosphorylated 4E-BP1 predicts for tumor recurrence and reduced survival in cervical carcinoma treated with postoperative radiotherapy
    Sergio Benavente
    Department of Radiation Oncology, Vall d Hebron University Hospital, Barcelona, Spain
    Int J Radiat Oncol Biol Phys 75:1316-22. 2009
  7. ncbi Epidermal growth factor receptor is a predictor of tumor response in locally advanced rectal cancer patients treated with preoperative radiotherapy
    Jordi Giralt
    Department of Radiation Oncology, Hospital Universitari Vall d Hebron, Barcelona, Spain
    Int J Radiat Oncol Biol Phys 54:1460-5. 2002
  8. ncbi Management of squamous cell carcinoma of the head and neck: updated European treatment recommendations
    Monica Ramos
    Department of Radiation Oncology, Vall d Hebron University Hospital, Passeig Vall d Hebron 119 129, Barcelona, Spain
    Expert Rev Anticancer Ther 10:339-44. 2010
  9. ncbi Management of painful chronic pancreatitis with single-dose radiotherapy
    Luisa Guarner
    Digestive Disease Research Unit, Hospital Universitari Vall d Hebron, Barcelona, Spain
    Am J Gastroenterol 104:349-55. 2009
  10. ncbi The gut microbiota predispose to the pathophysiology of acute postradiotherapy diarrhea
    Chaysavanh Manichanh
    Unité d Ecologie et de Physiologie du Système Digestif, INRA, Jouy en Josas, France
    Am J Gastroenterol 103:1754-61. 2008

Collaborators

Detail Information

Publications11

  1. ncbi Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer
    Jacques Bernier
    Department of Radio Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
    N Engl J Med 350:1945-52. 2004
    ..We compared concomitant cisplatin and irradiation with radiotherapy alone as adjuvant treatment for stage III or IV head and neck cancer...
  2. ncbi Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiation-induced diarrhea: results from multicenter, randomized, placebo-controlled nutritional trial
    Jordi Giralt
    Department of Radiation Oncology, Vall d Hebron University Hospital, Barcelona, Spain
    Int J Radiat Oncol Biol Phys 71:1213-9. 2008
    ..To determine whether a probiotic drink containing Lactobacillus casei DN-114 001 reduces the incidence of radiation-induced diarrhea in patients with gynecologic cancer...
  3. ncbi Pre-operative chemoradiotherapy with UFT and Leucovorin in patients with advanced rectal cancer: a phase II study
    Jordi Giralt
    Department of Radiation Oncology, Vall d Hebron University Hospital, Barcelona, Spain
    Radiother Oncol 89:263-9. 2008
    ....
  4. ncbi Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy
    Jordi Giralt
    Department of Radiation Oncology, Hospital Vall d Hebron, Barcelona, Spain
    Oncology 71:312-9. 2006
    ..To analyze the prognostic value of cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) in patients with locally advanced rectal cancer treated with preoperative radiotherapy...
  5. ncbi The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multicenter, retrospective analysis
    Jordi Giralt
    Department of Radiation Oncology, Hospital Universitari Vall d'Hebron, Barcelona, Spain
    Radiother Oncol 74:101-8. 2005
    ..88(1.1-7.8), P=0.036. CONCLUSIONS: EGFR is expressed in a significant number of rectal tumors. EGFR-positive expression before radiotherapy is an indicator for poor response and low disease-free survival...
  6. ncbi Overexpression of phosphorylated 4E-BP1 predicts for tumor recurrence and reduced survival in cervical carcinoma treated with postoperative radiotherapy
    Sergio Benavente
    Department of Radiation Oncology, Vall d Hebron University Hospital, Barcelona, Spain
    Int J Radiat Oncol Biol Phys 75:1316-22. 2009
    ....
  7. ncbi Epidermal growth factor receptor is a predictor of tumor response in locally advanced rectal cancer patients treated with preoperative radiotherapy
    Jordi Giralt
    Department of Radiation Oncology, Hospital Universitari Vall d Hebron, Barcelona, Spain
    Int J Radiat Oncol Biol Phys 54:1460-5. 2002
    ..The aim of this study was to determine the EGFR expression rate in locally advanced rectal cancer and to analyze whether EGFR expression predicts tumor response to preoperative radiotherapy...
  8. ncbi Management of squamous cell carcinoma of the head and neck: updated European treatment recommendations
    Monica Ramos
    Department of Radiation Oncology, Vall d Hebron University Hospital, Passeig Vall d Hebron 119 129, Barcelona, Spain
    Expert Rev Anticancer Ther 10:339-44. 2010
    ..Preclinical work in signaling pathways and other oncogenic factors (e.g., human papillomavirus infection) will be the key to improving outcomes of head and neck cancer patients in the future...
  9. ncbi Management of painful chronic pancreatitis with single-dose radiotherapy
    Luisa Guarner
    Digestive Disease Research Unit, Hospital Universitari Vall d Hebron, Barcelona, Spain
    Am J Gastroenterol 104:349-55. 2009
    ..We reasoned that anti-inflammatory radiotherapy, which has proven useful to alleviate other painful inflammatory painful disorders, might prove valuable for severely symptomatic patients with chronic pancreatitis...
  10. ncbi The gut microbiota predispose to the pathophysiology of acute postradiotherapy diarrhea
    Chaysavanh Manichanh
    Unité d Ecologie et de Physiologie du Système Digestif, INRA, Jouy en Josas, France
    Am J Gastroenterol 103:1754-61. 2008
    ..As there is no current clinical or experimental information on the role of the gut microbiota in this pathogenesis, we conducted a pilot observational study on the fecal microbiota in patients receiving pelvic radiotherapy...
  11. ncbi Postoperative radiotherapy with simultaneous chemotherapy in high-risk squamous cell carcinoma of the head and neck: a novel standard that opens new questions
    Jordi Giralt
    Clin Transl Oncol 7:181-2. 2005